- Home
- ATYR vs RMR Comparison
ATYR vs RMR Comparison
Compare ATYR & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | RMR |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 253.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ATYR | RMR |
|---|---|---|
| Price | $0.84 | $16.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $4.20 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.4M | 149.1K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 11.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $700,284,000.00 |
| Revenue This Year | $9,628.95 | $274.80 |
| Revenue Next Year | $156.94 | $3.85 |
| P/E Ratio | ★ N/A | $22.93 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $13.48 |
| 52 Week High | $7.29 | $18.09 |
Technical Indicators
Market Signals| Indicator | ATYR | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 43.50 | 44.80 |
| Support Level | $0.82 | $15.81 |
| Resistance Level | $0.85 | $16.84 |
| Average True Range (ATR) | 0.07 | 0.47 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 7.78 | 14.68 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.